Open Up a World
WHERE MORE THAN ONE PATIENT
TYPE CAN BE TREATED

Explore how DUPIXENT may help different types of patients achieve symptom control.

Signs and symptoms of
uncontrolled asthma1-3

 
  • Cough
  • Shortness of breath
  • Wheezing
  • Nighttime awakening due
    to asthma
  • Frequent exacerbations
  • Impaired lung function
    (airflow limitations)
  • Frequent albuterol use
  • Activity limitation due to asthma
INDICATION

DUPIXENT is indicated as an add-on maintenance treatment of adult and pediatric patients aged 6 years and older with moderate-to-severe asthma characterized by an eosinophilic phenotype or with oral corticosteroid dependent asthma. Limitation of Use: DUPIXENT is not indicated for the relief of acute bronchospasm or status asthmaticus.1

Help appropriate patients benefit from the only dual inhibitor indicated in moderate-to-severe asthma1

SEE THE RESULTS OF DUPIXENT

Patient profiles are representative and are not actual DUPIXENT patients. Examples of patients with moderate-to-severe asthma with an eosinophilic phenotype or with OCS-dependent asthma.

OCS, oral corticosteroid.


Get More Information
on the Clinical Trials
SEE THE FULL STUDY DESIGNS